课题基金 / 基金详情

项目摘要

项目成果

Paul Smith的其他基金

相似基金

相关文献

中文摘要
翻译
人们对在单个生物样品中同时检测多种不同蛋白质有着浓厚的兴趣。由于所收集样品尺寸的限制,这些测量必须在尽可能小的液体体积上进行。这种兴趣一直是生物医学应用微流体装置发展背后的驱动力之一。转向这些规模较小的系统有许多优点。首先,它们能够分析较小的样本量。其次,在毛细管电泳等应用中,微流体系统可以在比大型系统更短的时间内实现相同的分离分辨率。最后,分析装置尺寸的减小提高了开发便携式分析设备的可能性。
英文摘要
There is a strong interest in the simultaneous detection of a number of different proteins in a single biological sample. Limitations on the size of the collected sample require that these measurements be done on as small a volume of fluid as possible. This interest has been one of the driving forces behind the development of microfluidic devices for biomedical applications. The move to these smaller-scale systems has a number of advantages. First, they are capable of analyzing smaller sample volumes. Second, in applications such as capillary electrophoresis the microfluidic system can achieve the same separation resolution in much less time than a larger-scale system. Finally, the reduced size of the analysis setup raises the possibility of developing portable analytical devices. One device under development is capable of measuring eight different electrophoretic runs simultaneously, while another device, a multi-channel flow immunoassay, is intended to measure up to twenty different analytes in a single sample. This latter device holds great potential for monitoring the immune or hormonal status of new born infants or measuring different cellular pathways within a single patient sample. Other interests of our group include the design and development of devices capable of analyzing the secretions and physiology of single cells. Our facilities have now developed to a point where we are able to advise and collaborate with investigators on how to produce microfluidic devices that address their specific needs. In collaboration with scientists at NIST, LBPS has developed a microfluidic device for immunoassay that can simultaneously isolate and detect multiple proteins, and which can ultimately be used for a variety of clinical and research applications. Using the microfabrication facilities at NIST, we are able to make micrometer-scale glass-encapsulated microfluidic systems with any desired two-dimensional configuration. The channel device architecture has several advantages over existing array technology; for example, proteins are detected by single-point capture, and much smaller sample volumes can be used. In a second collaboration with NIST, LBPS developed an eight channel plastic device for electrophoretic separation of DNA fragments. Currently, our focus is to further develop this chip for proteomic applications. One important challenge, key to the successful implementation of these devices, is the ability to achieve real-time detection of fluorescent labels at high sensitivity. We have achieved 10pM, 10 Hz label detection in eight independent 50u channels in a plastic substrate using a novel ball-lens, fiber optic approach that couples to an imaging spectrograph with CCD detection that allows four labeling dyes to be used simultaneously.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Montana Pediatric Clinical Trials Site
  • 批准号:
    10688276
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2016
  • 负责人:
    Paul Smith
  • 依托单位:
Montana Pediatric Clinical Trials Site
  • 批准号:
    10064493
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2016
  • 负责人:
    Paul Smith
  • 依托单位:
Montana Pediatric Clinical Trials Site
  • 批准号:
    10472686
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2016
  • 负责人:
    Paul Smith
  • 依托单位:
Montana Pediatric Clinical Trials Site
  • 批准号:
    9461969
  • 项目类别:
  • 资助金额:
    $164.82万
  • 财政年份:
    2016
  • 负责人:
    Paul Smith
  • 依托单位:
海外基金